Efficacy News and Research

RSS
New data from phase 3 study of avanafil for treatment of ED announced

New data from phase 3 study of avanafil for treatment of ED announced

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Vertex Pharmaceuticals plans proof-of-concept clinical trials in RA and epilepsy

Vertex Pharmaceuticals plans proof-of-concept clinical trials in RA and epilepsy

Key mechanism for systemic delivery of RNAi therapeutics using LNPs discovered

Key mechanism for systemic delivery of RNAi therapeutics using LNPs discovered

Research determines and validates the efficacy of T category in IASLC's Staging Manual

Research determines and validates the efficacy of T category in IASLC's Staging Manual

Recent releases in Global Health

Recent releases in Global Health

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

Therma-Med develops plans to provide health and wellness products throughout North America

Therma-Med develops plans to provide health and wellness products throughout North America

NexMed updates corporate activities

NexMed updates corporate activities

Plexxikon commences dosing in PLX4032 Phase 3 trial for metastatic melanoma

Plexxikon commences dosing in PLX4032 Phase 3 trial for metastatic melanoma

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

FDA grants unconditional approval for World Heart's Levacor VAD BTT study

FDA grants unconditional approval for World Heart's Levacor VAD BTT study

AUA updates clinical practice guideline on female stress urinary incontinence

AUA updates clinical practice guideline on female stress urinary incontinence

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Novelos Therapeutics to conclude pivotal Phase 3 trial in advanced non-small cell lung cancer

Novelos Therapeutics to conclude pivotal Phase 3 trial in advanced non-small cell lung cancer

Access Pharmaceuticals completes enrollment for Prolindac monotherapy trail, begins combination study

Access Pharmaceuticals completes enrollment for Prolindac monotherapy trail, begins combination study

Additional education to liver transplant candidates increases live donation and donor evaluation

Additional education to liver transplant candidates increases live donation and donor evaluation

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

3Sbio submits registrational clinical trial application for Feraheme injection

3Sbio submits registrational clinical trial application for Feraheme injection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.